Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes

Clinical trial NCT06021145 · RECRUITING

Trial details

NCT number: NCT06021145
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2024-04-02
Primary completion: 2025-05-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.